(81 days)
Phacoemulsification of cataracts in the human eye.
Not Found
I am sorry, but based on the provided text, there is no information about acceptance criteria, device performance, a specific study, sample sizes, expert qualifications, adjudication methods, MRMC studies, standalone performance, or ground truth details.
The document is a 510(k) clearance letter from the FDA to Circuit Tree Medical, Inc. for "The Wave Digital Phaco System." It states that the device is substantially equivalent to legally marketed predicate devices for the indication of "Phacoemulsification of cataracts in the human eye."
This type of FDA letter confirms market clearance but does not typically include detailed study results, performance metrics, or information on how ground truth was established, which are usually found in the 510(k) summary or the full submission.
§ 886.4670 Phacofragmentation system.
(a)
Identification. A phacofragmentation system is an AC-powered device with a fragmenting needle intended for use in cataract surgery to disrupt a cataract with ultrasound and extract the cataract.(b)
Classification. Class II.